Mösges, R <br/><br/>
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial.  [electronic resource] 

 -  Allergy  Sep 2018 
 - 1842-1850 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1398-9995 
<br/><br/><label>Standard No.: </label>10.1111/all.13433  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allergens--administration & dosage<br/>Asthma--complications<br/>Case-Control Studies<br/>Desensitization, Immunologic--adverse effects<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Peptides--administration & dosage<br/>Poaceae--adverse effects<br/>Pollen--immunology<br/>Quality of Life<br/>Rhinitis, Allergic, Seasonal--complications<br/>Seasons<br/>Treatment Outcome